Bausch Health Companies Inc. (BHC)

Bausch Health Companies Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	9,916	9,518	8,663	8,025	8,328	7,924
Other Revenue	113	107	94	99	106	103
Revenue	10,029	9,625	8,757	8,124	8,434	8,027
Revenue Growth (YoY)	5.86%	9.91%	7.79%	-3.68%	5.07%	-6.67%
Cost of Revenue	2,942	2,782	2,559	2,364	2,394	2,249
Gross Profit	7,087	6,843	6,198	5,760	6,040	5,778
Selling, General & Admin	3,371	3,283	2,895	2,531	2,492	2,367
Research & Development	631	616	604	529	465	452
Other Operating Expenses	-	-	1	1	-	1
Operating Expenses	5,026	4,976	4,577	4,276	4,332	4,465
Operating Income	2,061	1,867	1,621	1,484	1,708	1,313
Interest Expense	-1,544	-1,388	-1,328	-1,464	-1,426	-1,534
Interest & Investment Income	48	33	26	14	7	13
Currency Exchange Gain (Loss)	-62	-47	-52	-8	7	-30
EBT Excluding Unusual Items	503	465	267	26	296	-238
Merger & Restructuring Charges	-62	-36	-95	-68	-73	-23
Impairment of Goodwill	-	-	-493	-824	-469	-
Gain (Loss) on Sale of Assets	6	10	3	5	2	1
Asset Writedown	-24	-29	-45	-10	-211	-112
Legal Settlements	-45	-220	-	-9	-356	-422
Other Unusual Items	252	-5	-80	752	-205	-107
Pretax Income	520	167	-390	-129	-1,024	-934
Income Tax Expense	199	239	221	83	-87	-375
Earnings From Continuing Operations	321	-72	-611	-212	-937	-559
Minority Interest in Earnings	41	26	19	-13	-11	-1
Net Income	362	-46	-592	-225	-948	-560
Net Income to Common	362	-46	-592	-225	-948	-560
Shares Outstanding (Basic)	373	368	365	362	359	355
Shares Outstanding (Diluted)	373	368	365	362	359	355
Shares Change (YoY)	1.50%	0.85%	0.80%	0.86%	1.10%	0.82%
EPS (Basic)	0.97	-0.13	-1.62	-0.62	-2.64	-1.58
EPS (Diluted)	0.97	-0.13	-1.62	-0.62	-2.64	-1.58
Free Cash Flow	1,095	1,260	817	-946	1,157	809
Free Cash Flow Per Share	2.94	3.42	2.24	-2.61	3.22	2.28
Gross Margin	70.67%	71.10%	70.78%	70.90%	71.61%	71.98%
Operating Margin	20.55%	19.40%	18.51%	18.27%	20.25%	16.36%
Profit Margin	3.61%	-0.48%	-6.76%	-2.77%	-11.24%	-6.98%
Free Cash Flow Margin	10.92%	13.09%	9.33%	-11.64%	13.72%	10.08%
EBITDA	3,286	3,134	2,885	2,878	3,260	3,138
EBITDA Margin	32.77%	32.56%	32.95%	35.43%	38.65%	39.09%
D&A For EBITDA	1,225	1,267	1,264	1,394	1,552	1,825
EBIT	2,061	1,867	1,621	1,484	1,708	1,313
EBIT Margin	20.55%	19.40%	18.51%	18.27%	20.25%	16.36%
Effective Tax Rate	38.27%	143.11%	-	-	-	-
Revenue as Reported	10,029	9,625	8,757	8,124	8,434	8,027

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q